Why is aseptic processing important in pharmaceutical manufacturing? The manufacturing of both sterile drugs and biological products can be achieved through terminal sterilization or aseptic ...
Dalton Pharma Services today announced that it has expanded it cGMP sterile powder filling capabilities as part of its ongoing focus of sterile manufacturing, supported by FedDev Ontario funding.
LEE — In the past several years, Berkshire Sterile Manufacturing has been significantly increasing its capabilities and expanding its potential market. This has included the development of two new ...
In this Pharma Matters Q&A, Anshul Gupte of PCI Pharma Services discusses investments and opportunities in sterile ...
Sterile manufacturing refers to the method of producing medications in which the drug product, container, and closure are meticulously sterilized before being distributed. The pharmaceutical sector ...
According to the National Cancer Institute, immunotherapies that enlist and strengthen the power of a patient’s immune system are the “fifth pillar” of cancer treatment adding to surgery, chemotherapy ...
Intensified regulator focus is pushing sterile operations away from personnel manipulations, elevating robotics from optional ...
DURHAM, N.C.--(BUSINESS WIRE)--Patheon N.V (NYSE: PTHN), a leading global provider of high-quality drug development and delivery solutions to the pharmaceutical and biopharma sectors, announced that ...
After years of manufacturing woes, Pfizer appeared to turn a corner earlier this year for its growing sterile injectables portfolio. But even with signs trending upward, Pfizer is preparing to exit an ...
An aging patient population and an increasingly consumer-driven healthcare environment fuel the demand for quick, convenient surgical procedures. The tools used in these procedures are more ...
Central sterile processing is essential for a safe and efficient operating room. Mistakes in sterilization can cause delays in surgery and patient infections, among other issues. Alecia Cooper, RN, BS ...
The US Food and Drug Administration (FDA) has issued warning letters to several drug manufacturers and compounders for violations of current good manufacturing practices (CGMP) and for marketing ...